BAM
TMDX icon

Blueshift Asset Management’s Transmedics TMDX Stock Holding History

Blueshift Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,358
Closed -$334K – 745
2026
Q1 		$334K Buy
3,358
+667
+25% +$87K 0.1% 310
2025
Q4 		$327K Buy
+2,691
New +$338K 0.09% 308
2024
Q4 		– Sell
-4,343
Closed -$682K – 509
2024
Q3 		$682K Buy
4,343
+537
+14% +$82.7K 0.17% 146
2024
Q2 		$573K Buy
+3,806
New +$457K 0.19% 145

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Blueshift Asset Management's TMDX Position: Q2 2026 in Review

Blueshift Asset Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 3,358 shares — an estimated $334K sold.

Blueshift Asset Management first reported a position in TMDX in Q2 2024 and held it in 4 quarters. The position peaked at $682K in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Blueshift Asset Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Blueshift Asset Management sold 3,358 Transmedics shares in Q2 2026, an estimated $334K.
  • Blueshift Asset Management first reported a position in Transmedics in Q2 2024 and held it in 4 quarters.
  • Blueshift Asset Management's Transmedics position peaked at $682K in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.